COO
Cooper Companies, Inc.

833
Mkt Cap
$16.29B
Volume
1.46M
52W High
$100.24
52W Low
$61.78
PE Ratio
43.38
COO Fundamentals
Price
$81.29
Prev Close
$82.80
Open
$82.27
50D MA
$79.51
Beta
0.79
Avg. Volume
3.22M
EPS (Annual)
$1.87
P/B
1.93
Rev/Employee
$272,826.67
Loading...
Loading...
News
all
press releases
WST Launches Synchrony S1 Prefillable Syringe at Pharmapack
West Pharmaceutical debuts the Synchrony S1 prefillable syringe at Pharmapack 2026, enhancing biologics, vaccines and home-care support.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
ITGR leans on R&D and MedTech scale after a solid Q3 2025, but slower product adoption and supplier reliance cloud the near-term outlook.
Zacks·3d ago
News Placeholder
BD and Ypsomed Expand Partnership to Target Growing Biologics Market
BDX expands its Ypsomed partnership with a 5.5 mL Neopak XtraFlow syringe, targeting rising demand for large-volume subcutaneous self-injection.
Zacks·3d ago
News Placeholder
Rakuten Investment Management Inc. Acquires New Position in The Cooper Companies, Inc. $COO
Rakuten Investment Management Inc. bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the third quarter, according to the company in its most recent 13F...
MarketBeat·3d ago
News Placeholder
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System
BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.
Zacks·4d ago
News Placeholder
The Cooper Companies, Inc. $COO Shares Acquired by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. MA lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 96.9% during the third quarter, according to its most recent 13F filing with the...
MarketBeat·5d ago
News Placeholder
The Cooper Companies, Inc. (NASDAQ:COO) Given Average Rating of "Moderate Buy" by Brokerages
The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has earned a consensus rating of "Moderate Buy" from the sixteen brokerages that are covering the company, MarketBeat reports. One equities...
MarketBeat·7d ago
News Placeholder
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of The Cooper Companies, Inc. (NASDAQ:COO)
Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of The Cooper Companies, Inc. (NASDAQ:COO). In a filing disclosed on January 12th, the Representative disclosed that...
MarketBeat·11d ago
News Placeholder
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
WST is riding on surging GLP-1 demand and HVP expansion. Yet, pricing pressure, tariff risks and contract manufacturing headwinds cloud the near-term outlook.
Zacks·11d ago
News Placeholder
COO or WST: Which Is the Better Value Stock Right Now?
COO vs. WST: Which Stock Is the Better Value Option?
Zacks·13d ago
<
1
2
...
>

Latest COO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.